司美格鲁肽 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "司美格鲁肽" in Chinese language version.

refsWebsite

Global rank Chinese rank

16web.archive.org

1^st place

3tga.gov.au

3,984^th place

1,603^rd place

3nih.gov

4^th place

5^th place

3europa.eu

68^th place

209^th place

3hres.ca

low place

2funnelback.com

low place

2medicines.org.uk

3,823^rd place

3,456^th place

1jjq.gov.cn

low place

1peptideshop.online

low place

1rxlist.com

7,927^th place

5,088^th place

europa.eu

ema.europa.eu

Ozempic EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-09-26]. （原始内容存档于2020-10-25）.
Rybelsus EPAR. European Medicines Agency (EMA). 2020-01-29 [2020-09-26]. （原始内容存档于2020-08-14）.
Wegovy EPAR. European Medicines Agency. 2021-11-11 [2022-03-11]. （原始内容存档于2022-07-02）.

funnelback.com

tga-search.clients.funnelback.com

Summary for ARTG Entry:315107 Ozempic 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen. Therapeutic Goods Administration (TGA). [2021-06-06]. （原始内容存档于2022-02-24）.
Summary for ARTG Entry: 346198 Rybelsus semaglutide 3 mg tablet blister pack. Therapeutic Goods Administration (TGA). [2022-02-23]. （原始内容存档于2022-02-24）.

hres.ca

pdf.hres.ca

Product Monograph Including Patient Medication Information – Ozempic semaglutide injection (PDF) (报告). Novo-Nordisk Canada. 2020-08-21 [Initial approval 4 January 2018] [2021-06-06]. （原始内容存档 (PDF)于2021-06-07）.
Product Monograph Including Patient Medication Information – Rybelsus semaglutide tablets (PDF) (报告). Novo-Nordisk Canada. 2020-03-30 [2021-06-06]. （原始内容存档 (PDF)于2021-12-14）.

hpr-rps.hres.ca

Regulatory Decision Summary – Rybelsus. Health Canada. 2014-10-23 [2022-06-04]. （原始内容存档于2022-06-05）.

jjq.gov.cn

世界上从来没有“减肥神药”_芜湖市政务公开平台. 鸠江区人民政府. 2024-06-28 [2024-11-18] （中文）.

medicines.org.uk

Ozempic 0.25 mg solution for injection in pre-filled pen – Summary of Product Characteristics (SmPC). (emc). 2021-04-09 [2021-06-06]. （原始内容存档于2021-06-06）.
Rybelsus – Summary of Product Characteristics (SmPC). (emc). 2020-11-25 [2021-06-06]. （原始内容存档于2021-06-06）.

nih.gov

dailymed.nlm.nih.gov

Ozempic- semaglutide injection, solution. DailyMed. [2021-06-05]. （原始内容存档于2021-06-05）.
Rybelsus- oral semaglutide tablet. DailyMed. [2021-06-05]. （原始内容存档于2021-06-05）.
Wegovy- semaglutide injection, solution. DailyMed. 2021-06-04 [2022-03-11]. （原始内容存档于2021-12-14）.

peptideshop.online

张文豹. Semaglutide for weight loss you need to know - semaglutide user guide. semaglutide user guide. 2024-04-29 （美国英语）.

rxlist.com

Cunha JP (编). Side Effects of Wegovy (Semaglutide Injection), Warnings, Uses. RxList (part of the WebMD network). 18 January 2023 [9 March 2023]. （原始内容存档于9 March 2023）.

tga.gov.au

AusPAR: Semaglutide. Therapeutic Goods Administration (TGA). 2020-12-02 [2022-02-23]. （原始内容存档于2022-02-24）.
Rybelsus APMDS. Therapeutic Goods Administration (TGA). 2022-02-22 [2022-02-23].
WEGOVY (Novo Nordisk Pharmaceuticals Pty Ltd). Therapeutic Goods Administration (TGA). 2022-10-07 [2023-04-07]. （原始内容存档于2023-04-14）.

web.archive.org

AusPAR: Semaglutide. Therapeutic Goods Administration (TGA). 2020-12-02 [2022-02-23]. （原始内容存档于2022-02-24）.
Summary for ARTG Entry:315107 Ozempic 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen. Therapeutic Goods Administration (TGA). [2021-06-06]. （原始内容存档于2022-02-24）.
Summary for ARTG Entry: 346198 Rybelsus semaglutide 3 mg tablet blister pack. Therapeutic Goods Administration (TGA). [2022-02-23]. （原始内容存档于2022-02-24）.
WEGOVY (Novo Nordisk Pharmaceuticals Pty Ltd). Therapeutic Goods Administration (TGA). 2022-10-07 [2023-04-07]. （原始内容存档于2023-04-14）.
Product Monograph Including Patient Medication Information – Ozempic semaglutide injection (PDF) (报告). Novo-Nordisk Canada. 2020-08-21 [Initial approval 4 January 2018] [2021-06-06]. （原始内容存档 (PDF)于2021-06-07）.
Product Monograph Including Patient Medication Information – Rybelsus semaglutide tablets (PDF) (报告). Novo-Nordisk Canada. 2020-03-30 [2021-06-06]. （原始内容存档 (PDF)于2021-12-14）.
Regulatory Decision Summary – Rybelsus. Health Canada. 2014-10-23 [2022-06-04]. （原始内容存档于2022-06-05）.
Ozempic 0.25 mg solution for injection in pre-filled pen – Summary of Product Characteristics (SmPC). (emc). 2021-04-09 [2021-06-06]. （原始内容存档于2021-06-06）.
Rybelsus – Summary of Product Characteristics (SmPC). (emc). 2020-11-25 [2021-06-06]. （原始内容存档于2021-06-06）.
Ozempic- semaglutide injection, solution. DailyMed. [2021-06-05]. （原始内容存档于2021-06-05）.
Rybelsus- oral semaglutide tablet. DailyMed. [2021-06-05]. （原始内容存档于2021-06-05）.
Wegovy- semaglutide injection, solution. DailyMed. 2021-06-04 [2022-03-11]. （原始内容存档于2021-12-14）.
Ozempic EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-09-26]. （原始内容存档于2020-10-25）.
Rybelsus EPAR. European Medicines Agency (EMA). 2020-01-29 [2020-09-26]. （原始内容存档于2020-08-14）.
Wegovy EPAR. European Medicines Agency. 2021-11-11 [2022-03-11]. （原始内容存档于2022-07-02）.
Cunha JP (编). Side Effects of Wegovy (Semaglutide Injection), Warnings, Uses. RxList (part of the WebMD network). 18 January 2023 [9 March 2023]. （原始内容存档于9 March 2023）.